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infection (as determined by two consecutive nega-
tive PCR tests), were available for analysis (Fig. S1 
in the Supplementary Appendix).
The group of persons with asymptomatic 
SARS-CoV-2 infection consisted of 58 passengers 
and 32 crew members, with median age of 59.5 
years (interquartile range, 36 to 68; range, 9 to 77). 
A total of 24 of these persons (27%) had coexist-
ing medical conditions, including hypertension 
(in 20%) and diabetes (9%). The first PCR test at 
the hospital was performed a mean of 6 days 
after the initial positive PCR test on the ship. 
The median number of days between the first 
positive PCR test (either on the ship or at the 
hospital) and the first of the two serial negative 
PCR tests was 9 days (interquartile range, 6 to 11; 
range, 3 to 21), and the cumulative percentages 
of persons with resolution of infection 8 and 15 
days after the first positive PCR test were 48% 
and 90%, respectively. The risk of delayed reso-
lution of infection increased with increasing age 
(mean delay in resolution for an increase in age 
from 36 to 68 years, 4.41 days; 95% CI, 2.28 to 
6.53) (Fig. 1).
In this cohort, the majority of asymptomati-
cally infected persons remained asymptomatic 
throughout the course of the infection. The time 
to the resolution of infection increased with in-
creasing age.
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To the Editor: In their article, Ackermann et al. 
(online May 21; July 9 issue)1 showed that vascu-
lar lesions in the lung — namely, sprouting and 
intussusceptive angiogenesis, along with disrup-
tion of intercellular junctions — were found in 
patients who died from coronavirus disease 2019 
(Covid-19). The authors hypothesized that the 
mechanism responsible for the vasculopathy was 
a direct viral effect on endothelial cells or peri-
vascular inflammation, but they did not com-
ment on pericytes. Pericytes are perivascular cells 
that have a key role in the maintenance of 
 microvessel integrity; their loss triggers both 
sprouting and intussusceptive angiogenesis.2 Be-
cause they are among the cells that have the 
highest expression of angiotensin-converting 
enzyme 2 (ACE2), the receptor of severe acute re-
spiratory syndrome coronavirus 2 (SARS-CoV-2),3,4 
pericytes could be a target of the virus. We re-
cently showed a profound loss of pericytes coex-
isting with preserved endothelial cells in alveolar 
capillaries of the lungs of patients with Covid-19.5 
Could the authors comment on the possibility 
that alteration of pericytes by a direct effect of 
SARS-CoV-2 may be the initial trigger of the mi-
crovasculopathy?
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To the Editor: Ackermann et al. observed wide-
spread vascular abnormalities in autopsy speci-
mens from patients with Covid-19 pneumonia, 
including thrombosis, microangiopathy, and a 
higher degree of angiogenesis than was seen in 
patients with influenza pneumonia. These histo-
logic findings suggest possible mechanisms for 
the pulmonary vascular abnormalities on com-
puted tomographic (CT) pulmonary angiogra-
phy that we recently described in patients with 
Covid-19 pneumonia.1
Although focal vessel enlargement within 
ground-glass opacities was described in early 
imaging investigations of Covid-19,2 we have 
noted additional extensive vascular abnormali-
ties, including regionally dilated segmental 
and subsegmental pulmonary vessels, increased 
branching and tortuosity of pulmonary vascula-
ture, and perfusion abnormalities on dual-energy 
CT (Fig. 1). As previously suggested,1 vascular 
injury leading to abnormal vasoregulation and 
vascular shunting may be one explanation for 
the presence of hypoxemia that is disproportion-
ate to the reduction in pulmonary compliance in 
some patients with Covid-19 pneumonia.3
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To the Editor: Ackermann et al. published an 
image obtained by transmission electron micros-
copy that depicted ultrastructural features of en-
dothelial cell destruction. We measured the di-
ameters of the two structures pinpointed in their 
Figure 3D as 250±7 nm in one and 264±13 nm in 
the other (mean [±SD] of four measurements). 
We also conducted a meta-analysis of published 
studies of SARS-CoV-2 (Fig. 1), in which we found 
a mean virion size of 60±9 nm in images from 
thin-section transmission electron microscopy. 
The two dark spots in the image provided by 
Figure 1. A 65-Year-Old Man with Covid-19 Pneumonia 
and Acute Respiratory Distress Syndrome.
Panel A is an axial CT image obtained at lung-window 
settings, showing large regions of ground-glass opacity 
in the lower lungs bilaterally; a pronounced mosaic per-
fusion pattern is present, in the absence of any visible 
pulmonary emboli. Subsegmental pulmonary vessels 
are dilated within areas of ground-glass opacity (arrows), 
whereas vessels in areas of clear lung are smaller in 
 diameter. The distal subsegmental pulmonary vessels 
are engorged and tortuous (arrowheads). Panel B is 
a corresponding axial dual-energy CT image showing 
heterogeneous distribution of iodine in the lungs, sug-
gesting higher perfusion of the areas of ground-glass 
opacity containing enlarged vessels (asterisks) and 
lower perfusion of the clear regions. Decreased per-
fusion in the posterior lungs corresponds to a small 
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Ackermann et al. are thus approximately 4 times 
as large as expected for SARS-CoV-2 virions, and 
they are not located within a cell membrane as 
described. They also lack viral nucleocapsids and 
are not within vesicles. Since the possibility of 
confusing SARS-CoV-2 with other subcellular 
structures is known,1,2 we ask the authors whether 
they have other data to support the identification 
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The authors reply: We share the interest of 
Burel-Vandenbos et al. in the potential involvement 
of pericytes in the pathobiology of Covid-19. Peri-
cytes have been implicated in several processes 
relevant to Covid-19, including blood-flow regu-
lation and angiogenesis.1 The experimental chal-
lenge is the rarity of pericytes in the lungs and 
the lack of exclusive markers for reproducible 
histologic identification. The α smooth-muscle 
actin (α-SMA)–positive cells in patients with 
Covid-19 may reflect not only pericytes but also 
parenchymal2 and mesothelial-derived3 myofi-
broblasts, which have previously been implicated 
in lung repair, remodeling, and intussusceptive 
angiogenesis.
Som et al. show striking changes in the lung 
of a patient with Covid-19. In their previous cor-
respondence,4 the authors showed obstructed 
airspaces and associated vasoconstriction con-
sistent with intact vasoregulation. Here, the im-
ages show hypoperfusion of apparently unob-
structed airways. Potentially catastrophic for 
this patient, these findings are consistent with 
our observations of vasodysregulation in pa-
tients with Covid-19. We note that the marked 
vasoconstriction and vascular tortuosity described 
Figure 1. Comparison of SARS-CoV-2 Virion Sizes.
Shown is a comparison of virion size based on our meta-analysis of images from thin-section transmission electron 
microscopy from 12 sources (published studies as well as images from the Chinese National Institute for Viral Dis-
ease Control and Prevention and the University of Hong Kong) (mean [±SD] diameter, 60±9 nm) and the sizes of 
the two structures referred to as SARS-CoV-2 in Figure 3D of the article by Ackermann et al. (mean diameters from 
four measurements, 250±7 nm and 264±13 nm). In the box-and-whisker plots, the bold vertical line indicates the 
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by Som et al. are illustrated by the microCT three-
dimensional reconstructions included in the 
Supplementary Appendix of our article (available 
at NEJM.org).
Scholkmann and Nicholls remind us of the 
potential variability of calibration in transmis-
sion electron microscopy and of the care neces-
sary in interpreting absolute size in planar 
transmission electron micrographs — especially 
when comparing images of RNA viruses ob-
tained in glutaraldehyde-fixed tissue and tissue 
culture. The image in our article was chosen to 
highlight the dramatic ultrastructural changes 
in the endothelium. In Figure 1, a transmission 
electron micrograph of the endothelium from a 
patient with Covid-19, we show numerous endo-
thelial viruslike particles, ranging in size from 
60 nm to 150 nm — that is, a size range consis-
tent with SARS-CoV-2 virus particles. To confirm 
the presence of SARS-CoV-2 virus in the lungs in 
our study, we measured viral RNAs in the three 
study groups and found high levels of SARS-
CoV-2 RNA (Table S1 in the Supplementary 
Appendix of this letter, available at NEJM.org).
Maximilian Ackermann, M.D.
Johannes Gutenberg University Mainz
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Figure 1. Viruslike Particles within the Endothelial Cells of a Lung from a Patient with Covid-19.
Shown is a transmission electron micrograph of viruslike particles within the endothelial cells of a lung (after alde-
hyde fixation) from a patient with Covid-19. In Panel B (an enlarged view of the boxed area in Panel A), numerous 
particles in the size range of 60 nm to 150 nm are visible (arrowheads). (Images prepared in collaboration with 
G. Griffiths, J. Wohlmann, and N. Roos, University of Oslo.)
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